- Home
- KLXE vs VTGN Comparison
KLXE vs VTGN Comparison
Compare KLXE & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- VTGN
- Stock Information
- Founded
- KLXE 2018
- VTGN 1998
- Country
- KLXE United States
- VTGN United States
- Employees
- KLXE N/A
- VTGN N/A
- Industry
- KLXE Oilfield Services/Equipment
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- KLXE Energy
- VTGN Health Care
- Exchange
- KLXE Nasdaq
- VTGN Nasdaq
- Market Cap
- KLXE 35.8M
- VTGN 87.2M
- IPO Year
- KLXE N/A
- VTGN N/A
- Fundamental
- Price
- KLXE $1.84
- VTGN $2.91
- Analyst Decision
- KLXE
- VTGN
- Analyst Count
- KLXE 0
- VTGN 0
- Target Price
- KLXE N/A
- VTGN N/A
- AVG Volume (30 Days)
- KLXE 86.5K
- VTGN 367.0K
- Earning Date
- KLXE 10-30-2025
- VTGN 11-06-2025
- Dividend Yield
- KLXE N/A
- VTGN N/A
- EPS Growth
- KLXE N/A
- VTGN N/A
- EPS
- KLXE N/A
- VTGN N/A
- Revenue
- KLXE $667,400,000.00
- VTGN $646,000.00
- Revenue This Year
- KLXE N/A
- VTGN $46.91
- Revenue Next Year
- KLXE $3.97
- VTGN $504.34
- P/E Ratio
- KLXE N/A
- VTGN N/A
- Revenue Growth
- KLXE N/A
- VTGN N/A
- 52 Week Low
- KLXE $1.46
- VTGN $1.90
- 52 Week High
- KLXE $7.40
- VTGN $3.88
- Technical
- Relative Strength Index (RSI)
- KLXE 48.29
- VTGN 39.59
- Support Level
- KLXE $1.77
- VTGN $3.45
- Resistance Level
- KLXE $1.94
- VTGN $3.64
- Average True Range (ATR)
- KLXE 0.13
- VTGN 0.21
- MACD
- KLXE -0.01
- VTGN -0.07
- Stochastic Oscillator
- KLXE 26.19
- VTGN 6.73
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.